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Association between hyperlipidemia and microalbuminuria in lin-dependent diabetes mellitus (NIDDM) [1]. In both
essential hypertension. IDDM and NIDDM patients, microalbuminuria also
Background. Some patients with essential hypertension predicts cardiovascular morbidity and mortality [2].manifest greater than normal urinary albumin excretion
Some evidence also indicates that microalbuminuria may(UAE). A few retrospective studies have suggested that there
predict cardiovascular events and perhaps early renalis an association between microalbuminuria and cardiovascular
risk. The reasons for this association are not well established, damage in patients with essential hypertension. The pos-
and they are the object of this review. sible reasons underlying the association between mi-
Results. We found that hypertensive patients with microal- croalbuminuria and increased incidence of cardiovascu-buminuria manifest greater levels of blood pressure, particu-
lar and renal events are outlined in this review.larly at night. Serum levels of cholesterol, triglycerides, and
uric acid in patients with microalbuminuria were higher than
levels in those with normal UAE, whereas levels of high-density
MICROALBUMINURIA IN ESSENTIALlipoprotein cholesterol in patients with microalbuminuria were
HYPERTENSION: INCIDENCE ANDlower than levels in patients with normal UAE. Patients with
microalbuminuria manifest a greater incidence of insulin resis- RELATIONSHIP WITH LEVELS OF
tance, and thicker carotid arteries. After a follow-up of seven BLOOD PRESSURE
years we observed that 12 cardiovascular events occurred
The prevalence of microalbuminuria in patients withamong 54 (21.3%) patients with microalbuminuria, and only
two such events among 87 patients with normal UAE (P , essential hypertension varies enormously among differ-
0.0002). Stepwise logistical regression analysis showed that ent studies, with rates ranging between 5 and 37% [3].
UAE, cholesterol level and diastolic blood pressure were inde- In a study of 11,343 nondiabetic hypertensive patients
pendent predictors of the cardiovascular outcome. The rate of
with a mean age of 57 years, microalbuminuria was pres-clearance of creatinine from patients with microalbuminuria
ent in 32% of men and 28% of women (P , 0.05) anddecreased more than did that from those with normal urinary
albumin excretion. increased with age, severity and duration of hypertension
Conclusions. These studies suggest that hypertensive indi- [4]. Some studies have failed to find a correlation be-
viduals with microalbuminuria manifest a variety of biochemi- tween office blood pressure and urinary albumin excre-
cal and hormonal derangements with pathogenic potential,
tion in patients with essential hypertension [5], but otherswhich result in greater incidence of cardiovascular events and
have shown a significant correlation between these twoa greater decline in renal function than do patients with
variables [6]. Usually, better correlations between levelsnormal UAE.
of blood pressure and UAE are observed when continu-
ous ambulatory measurements are used instead of occa-
sional blood pressure readings in the office [7]. We ob-The term microalbuminuria indicates a urinary albu-
served that patients with essential hypertension andmin excretion (UAE) of 30 to 300 mg/24 hr or 20 to 200
microalbuminuria manifest a blunted or absent noctur-mg/min.
nal dipping of blood pressure. Hypertensive patients withSeveral studies have indicated that microalbuminuria
no nocturnal dipping of blood pressure (nondippers) dis-is a marker of glomerular damage, and predicts the devel-
played greater UAE than “dippers” [8].opment of overt proteinuria and progressive renal failure
in patients with insulin-dependent (IDDM) and noninsu-
MICROALBUMINURIA AND SERUM LIPIDS
In patients with essential hypertension, the combinedKey words: hypertension, microalbuminuria, blood pressure, cardio-
vascular risk, urinary albumin excretion. presence of microalbuminuria and hyperlipidemia is fre-
quent. We have shown higher serum levels of lipopro- 1999 by the International Society of Nephrology
S-10
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or with nondiabetic nephropathy [14]. A substantial body
of evidence supports the hypothesis that lipids may be
involved in glomerulosclerosis and the progression of
renal disease. Cholesterol-enriched diets may increase
UAE and cause glomerulosclerosis in different animal
species, particularly when combined with hypertension.
Pharmacological agents that lower serum lipids amelio-
rate renal injury in several experimental models of renal
disease [15]. In human subjects, administration of lipid
lowering agents results in a decrease of UAE [16]. The
mechanism(s) responsible for the deleterious effects of
lipids on glomerular injury are not yet well established.
The resemblance between glomerular mesangial cells
and vascular smooth muscle cells and the important role
played by the latter cells in the process of atherosclerosis
Fig. 1. Serum levels of lipoproteins in 76 normotensive healthy subjects suggests that accumulation of lipids in the mesangial
(h), 87 patients with essential hypertension and normal urinary albumin cells may cause or accelerate glomerulosclerosis. Theexcretion ( ; UAE) and 64 hypertensive patients with microalbuminu-
accumulation of lipids in mesangial cells or glomerularria (j). *Values in patients with microalbuminuria were significantly
(P , 0.01 by ANOVA) greater than in hypertensive patients with macrophages, along with collagen, laminin and fibro-
normal UAE and normotensive healthy subjects. nectin, also supports some similarities between the pro-
cess of atherosclerosis and glomerulosclerosis. Klahr,
Schreiner and Ichikawa have suggested that mesangial
cells exposed to increased amounts of lipoproteins maytein(a), low-density lipoprotein (LDL) cholesterol, and
incorporate lipids, which in turn may stimulate their pro-triglycerides, and lower levels of high-density lipoprotein
liferation and lead to excessive deposition of glomerular(HDL) cholesterol in hypertensive patients with microal-
basement membrane products and to progressive glom-buminuria compared with patients without microalbumi-
erulosclerosis [17].nuria. (Fig. 1) Using multiple regression analysis we ob-
served that lipoprotein(a) and nocturnal blood pressure
values were among several variables that best correlate MICROALBUMINURIA, INSULIN RESISTANCE
with microalbuminuria [9]. Haffner et al also observed AND HYPERINSULINEMIA IN
higher serum levels of triglycerides and lower HDL cho- ESSENTIAL HYPERTENSION
lesterol in nondiabetic subjects with microalbuminuria Several investigators have described the presence of
than in subjects without microalbuminuria [10], while insulin resistance and hyperinsulinemia in a substantial
others have confirmed a significant correlation between number of patients with essential hypertension [18], and
UAE and levels of triglycerides or apolipoprotein B [11]. suggested hyperinsulinemia as a risk factor for athero-
One possible explanation for the association between sclerotic cardiovascular diseases.
microalbuminuria and hyperlipidemia is that the urinary The mechanisms by which insulin resistance, hyperin-
loss of protein may cause the increase in serum levels of sulinemia, or both may increase the risk of cardiovascular
lipoproteins. This is supported by evidence that urinary disease are not well established. The plasma insulin re-
losses of large amounts of proteins may lead to increased sponse to an oral glucose load was enhanced in hyperten-
serum levels of total and LDL cholesterol as well as sive patients compared with control subjects [19]. A sig-
lipoprotein(a). Studies in diabetic patients have indi- nificant direct correlation was present between insulin
cated that even losses of small amounts of albumin in area-under-the-curve and urinary albumin excretion
the urine may be associated with substantial alterations rate. Using the euglycemic clamp technique, we also
of serum lipoproteins [12]. observed a 35% reduction of the peripheral glucose up-
An alternative explanation for the association be- take stimulated by insulin in patients with essential hy-
tween microalbuminuria and hyperlipidemia is that pertension and microalbuminuria [20]. This appeared to
hyperlipidemia causes renal damage that results in in- be secondary to a reduction of glycogen synthesis in
creased UAE. Many authors believe that lipid ab- skeletal muscle cells. Doria et al showed a significant
normalities may contribute to renal damage by a mecha- correlation between UAE and insulin resistance in pa-
nism analogous to atherogenesis. Recent studies have tients with essential hypertension. In all, the data support
shown that hyperlipidemia may play a role in the pro- microalbuminuria as a consistent correlate of hyperinsu-
gression of renal disease [13], both in experimental ne- linemia and insulin resistance in normotensive and hy-
pertensive individuals [21].phropathy in animals as well as in patients with diabetic
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The significance of the association between hyperinsu- ventricular hypertrophy [28], thickness of the carotid
artery, myocardial ischemia [29], coronary heart disease,linemia, insulin resistance and microalbuminuria in
essential hypertension is uncertain. Because microal- peripheral vascular disease [30], stroke, and hypertensive
retinopathy. In a study of 11,343 nondiabetic hyperten-buminuria and insulin resistance occur in nondiabetic nor-
motensive subjects with a genetic predisposition for hy- sive patients, among patients with microalbuminuria,
31% had coronary artery disease, 24% had left ventricu-pertension [22], microalbuminuria and enhanced plasma
insulin response to glucose could both be genetically lar hypertrophy, 6% had had a stroke, and 7% had pe-
ripheral vascular disease. In patients without microal-determined and cosegregate with the hypertensive sta-
tus. Alternatively, insulin resistance or hyperinsulinemia, buminuria, these rates were 22%, 14%, 4%, and 5%,
respectively (P , 0.001). Further, in patients with coro-or both, could be causally related to microalbuminuria.
Finally, the enhanced plasma insulin response to glucose, nary artery disease, left ventricular hypertrophy, stroke,
and peripheral vascular disease, microalbuminuria wasinsulin resistance and microalbuminuria could be a con-
sequence of hypertension. significantly greater than in patients who did not have
these complications (P , 0.001) [4].Insulin could increase UAE directly or indirectly
through a variety of mechanisms. Insulin could contrib- We performed a retrospective cohort analysis of 141
hypertensive individuals followed-up for approximatelyute to arteriosclerosis, renal damage and microalbuminu-
ria through its effects on blood pressure, lipid metabo- seven years. Fifty-four patients had microalbuminuria
and 87 had normal UAE. At baseline, the two groupslism, or through its throphic actions on vascular smooth
muscle cells. Insulin infusion into femoral arteries of had similar age, weight and blood pressure, but serum
cholesterol, triglycerides, and uric acid were higher andanimals induced intimal and medial proliferation and
accumulation of cholesterol and fatty acids [23]. In vitro, HDL cholesterol lower in patients with microalbuminu-
ria than in those with normal UAE. During follow-up,insulin can stimulate the proliferation of smooth muscle
cells and collagen deposition by growth-promoting fac- 12 cardiovascular events occurred in the 54 patients with
microalbuminuria and only two events in the 87 patientstors [24]. Insulin can increase cholesterol and triglycer-
ides synthesis and enhance LDL-receptor activity in arte- with normal UAE. Multiple regression analysis showed
that UAE cholesterol and diastolic blood pressure wererial smooth muscle cells, fibroblasts and mononuclear
cells [25]. independent predictors of cardiovascular outcome [31].
In conclusion, the presence of microalbuminuria inAn alternative hypothesis is that insulin may alter glo-
merular hemodynamics and/or glomerular permeability patients with essential hypertension carries an increased
risk of cardiovascular events. Although the mechanismsdirectly or by interfering with other factors such as cate-
cholamines, angiotensin II, glucagone or sodium reten- underscoring this association are not clear, it is plausible
that the increased incidence of cardiovascular events intion. Insulin may contribute to the salt-sensitivity of
blood pressure by causing sodium retention [26] or via these patients may be due, at least in part, to the presence
of lipid abnormalities.activation of the sympathetic nervous system. Salt-sensi-
tive individuals manifest an abnormal renal hemody-
namic response to high salt intake characterized by in- MICROALBUMINURIA AND
creased filtration fraction and intraglomerular pressure, NEPHROANGIOSCLEROSIS
and greater UAE than salt resistant patients [28]. Insulin
Data from the United States Renal Data Systemcould increase UAE by directly altering glomerular
(USRDS) show that over the past decade, the incidencemembrane permeability, or endothelial function.
of renal failure as a consequence of essential hyperten-Finally, both insulin resistance and microalbuminuria
sion has steadily increased. This phenomenon is particu-could be the result of alterations of the microcirculation
larly striking when one considers that definite progresscaused by long standing hypertension. This explanation
has been made in the treatment of established hyperten-seems less likely, because hyperinsulinemia, insulin resis-
sion and in the prevention of other cardiovascular com-tance and microalbuminuria may precede the appear-
plications. Can we predict the patients at risk for devel-ance of high blood pressure and are not found in all
oping renal failure due to hypertension, and morepatients with established hypertension.
specifically is microalbuminuria such a predictor?
Schmieder et al followed a group of hypertensive sub-
MICROALBUMINURIA AND jects with normal renal function for six years, and ob-
CARDIOVASCULAR DISEASE served no correlation between baseline urinary protein
excretion and worsening of renal function [32]. For fiveThe increasing interest in microalbuminuria in essen-
tial hypertension derives, in large part, from the recogni- years Ruilope et al studied a group of hypertensive sub-
jects with and without microalbuminuria who were main-tion that an increase in UAE is associated with a greater
incidence of cardiovascular morbid events, such as left tained on antihypertensive therapy consisting of diuretics
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and hypertension in initiation of glomerular injury. Kidney Intand B-blockers alone or in combination. They observed
41:1254–1261, 1992
that patients who at baseline evaluation manifested mi- 15. Keane WF, Mulcahy WS, Kasiske BL, Kim Y, O’Donnell MP:
croalbuminuria, showed a greater reduction of renal Hyperlipidemia and progressive renal disease. Kidney Int 39 (Suppl
31):S41–S48, 1991function then patients without microalbuminuria [33].
16. Tonolo G, Ciccarese M, Brizzi P, Puddu L, Secchi G, Calvia
In a retrospective analysis of 141 hypertensive indiv- P, Atzeni MM, Melis MG, Maioli M: Reduction of albumin
iduals followed for approximately seven years, we excretion rate in normotensive microalbuminuric type 2 diabetic
patients during long-term simvastatin treatment. Diabetes Careobserved a greater decrease of creatinine clearance
20:1891–1895, 1997among hypertensive patients with microalbuminuria 17. Klahr S, Schreiner G, Ichikawa I: The progression of renal
than among those with normal UAE (2 12.1 6 2.77 vs. disease. N Engl J Med 318:1657–1666, 1988
18. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleg-2 7.1 6 0.88 ml/min; P , 0.05) [31].
gini M, Graziadei L, Pedrinelli R, Brandi L, Bevilacqua S:
Insulin resistence in essential hypertension. N Eng J Med 317:350–
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